This is a preview of subscription content, log in via an institution to check access.
References
Andriulli A., Gindro T., Piantino P., Masoero G., Cavallini G., Farini R., Piazzi L., Dobrilla G., Naccarato R., Scuro L. A.: Efficacy of CA 199, TPA and CEA assays in pancreatic cancer—Digestion28, 9, 1983.
Armitage P.: Statistical methods in medical research. Blackwell Sci. Publ. Oxford Edinburgh, 1971.
Björklund B.: Tissue polypeptide antigen (TPA): biology and biochemistry. Improved assay methodology, clinical significance in cancer and other conditions, and future outlook— Antibiot. and Chemother.22, 16, 1978.
Björklund B.: On the nature and clinical use of tissue polypeptide antigen (TPA)—Tumordiagnostik.1, 9, 1980.
Björklund B., Björklund V., Lundström R., Eklund G.: Tissue polypeptide antigen (TPA) in human cancer defense responses. In: Reticuloendothelial system in health and disease: immunologic and pathologic aspects. Plenum Press, New York, 1976.
Guenther W. C.: Analysis of variance. Prentice-Hall Inc., Englewood Cliffs, New York, 1934.
Menendez-Botet C. J., Oettgen H. F., Pinsky C. M., Schwartz M. K.: A preliminary evaluation of tissue polypeptide antigen in serum or urine for both) of patients with cancer or benign neoplasms—Clin. Chem.24, 868, 1978.
Mross K., Mross B., Wolfrun D. I., Rauschecker H.: Determination of TPA levels in breast cancer and controls—Klin. Wschr.61, 461, 1983.
Schlegel M., Luthgens G., Eklund G., Björklund B.: Correlation between activity in breast cancer and CEA, TPA and eighteen common laboratory procedures and the improvement by combined use of CEA and TPA—Tumordiagnostik1, 6, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Panucci, A., De Silvestro, G., Fabris, C. et al. Serum tissue polypeptide antigen in chronic pancreatic disease. Does hepatic damage have any influence?. La Ricerca Clin. Lab. 14, 425–429 (1984). https://doi.org/10.1007/BF02904866
Issue Date:
DOI: https://doi.org/10.1007/BF02904866